Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Fatigue and Other Patient-Reported Outcomes in Patients With RRMS who Switched to Ocrelizumab: 4-Year Data From CASTING-LIBERTO

Author:Kister, Ilya   Benedict, Ralph   Comi, Giancarlo   Cutter, Gary   Oreja Guevara, Celia   Clinch, Susanne   Kuenzel, Thomas   Dirks, Petra   Vermersch, Patrick   

Session Name:P6: MS Clinical Trials  

Topic:MS and Inflammatory Disease  

Program Number:P6.010  

Author Institution:New York University Langone Medical Center, Multiple Sclerosis Comprehensive Care Center, New York, NY, USA, Passaic, NJ  Jacobs School of Medicine and Biomedical Sciences, Department of Neurology, University of Buffalo, NY, USA, Buffalo, NY  Vita-Salute San Raffaele University and Casa di Cura del Policlinico, Milan, Italy, Milan, Italy  Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA, Birmingham, AL  Hospital Clinico San Carlos, Madrid, Spain, Madrid, Spain  Roche Products Ltd, Welwyn Garden City, United Kingdom  F. Hoffmann-La Roche Ltd, Basel, Switzerland, Welwyn Garden City, United Kingdom  F. Hoffmann-La Roche Ltd, Basel, Switzerland, Grenzach-Wyhlen, Germany  Univ. Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France, Lille, France  

Anti-seizure Medication Use and Outcomes in Older Adults with Acute Traumatic Brain Injury

Author:Aemaz Ur Rehman, Muhammad   Saim, Muhammad   Bento Fernandes, Marta   Edlow, Brian   Moura, Lidia   Zafar, Sahar   

Session Name:P8: Neurocritical Care: Status Epilepticus and Seizures  

Topic:Neurocritical Care  

Program Number:P8.002  

Author Institution:Massachusetts General Hospital, Boston, MA  

Clinical trial protocol: TRANSCEND 1 – an observational study of patients with moderate Parkinson’s disease

Author:Gesine, Paul-Visse   Widner, Håkan   Bergholdt, Regine   Frimer-Larsen, Helle   Mathiasen, Ida Stenfeldt   Nielsen, Anne Møller   Barker, Roger   

Session Name:P2: Movement Disorders: Clinical Trials in Parkinson's Disease 2  

Topic:Movement Disorders  

Program Number:P2.002  

Author Institution:Translational Neurology Group, Lund University, Lund, Sweden  Skåne University Hospital, Lund, Sweden  Stem cell R&D, Novo Nordisk A/S, Måløv, Denmark  Novo Nordisk A/S, Søborg, Denmark  WT-MRC Cambridge Stem Cell Institute/Department of Clinical Neuroscience, University of Cambridge, Cambridge, United Kingdom  

Optical Coherence Tomography Angiography (OCTA) Retinal Imaging Can Detect Burden of Small Vessel Disease and Amyloid Deposition in the Brain

Author:Bermudez, Camilo   Lesnick, Timothy   More, Swati   Ramanan, Vijay   Knopman, David   Vemuri, Prashanthi   Petersen, Ronald   Graff-Radford, Jonathan   Chen, John   

Session Name:P11: Cerebrovascular Disease and Interventional Neurology: Neuroimaging and Secondary Stroke Prevention  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P11.001  

Author Institution:Mayo Clinic, Rochester, MN  University of minnesota, Minneapolis, MN  

Overall Survival Outcome In Patients With New Treatment Approaches For Glioblastoma Multiforme In Randomized Controlled Trials

Author:Castillo Vaca, María   Flores Arreola, Marcos   Bermúdez Faz, Sergio   Chávez Castillo, David Alejandro   Chávez Castillo, Eyra Montserrat   Carrillo Rodríguez, Sergio Manuel   Estrada Posadas, María Fernanda   Estrada Ortega, Thania Fabiola   Rojas Martínez, María Fernanda   Zamorano Serrano, Raul   

Session Name:P3: Neuro-oncology: Advancing Care for Patients with Brain Tumors  

Topic:Neuro-oncology  

Program Number:P3.004  

Author Institution:Universidad Autónoma de San Luis Potosi, UASLP, San Luis Potosí, SLP, Mexico  Universidad Autónoma de San Luis Potosi, UASLP, San Luis Potosí, Mexico  Universidad Autónoma de San Luis Potosi, UASLP, San Luis Potosi, Mexico